Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Health Catalyst Inc

HCAT
Current price
7.61 USD +0.44 USD (+6.14%)
Last closed 7.18 USD
Sector Healthcare
Industry Health Information Services
Exchange NASDAQ
Capitalization 440 259 808 USD
Yield for 12 month -28.61 %
Week
Month
Year
HCAT
21.11.2021 - 28.11.2021

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company offers data operating system data platform for analytics, and application development and interoperability that provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications designed to analyze the problems faced across clinical and quality, population health, and financial and operational use cases. It also provides services expertise, which include data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah. Address: 10897 South River Front Parkway, South Jordan, UT, United States, 84095

Analytics

WallStreet Target Price

11.5 USD

P/E ratio

Dividend Yield

Current Year

+276 236 000 USD

Last Year

+241 926 000 USD

Current Quarter

+73 773 000 USD

Last Quarter

+73 213 000 USD

Current Year

+133 187 000 USD

Last Year

+117 572 000 USD

Current Quarter

+31 986 000 USD

Last Quarter

+33 775 000 USD

Key Figures HCAT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -60 927 000 USD
Operating Margin TTM -30.4 %
PE Ratio
Return On Assets TTM -8.06 %
PEG Ratio
Return On Equity TTM -30.06 %
Wall Street Target Price 11.5 USD
Revenue TTM 290 016 000 USD
Book Value 6.7 USD
Revenue Per Share TTM 5.22 USD
Dividend Share
Quarterly Revenue Growth YOY 7.9 %
Dividend Yield
Gross Profit TTM 135 561 000 USD
Earnings Share -2.24 USD
Diluted Eps TTM -2.24 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin -42.62 %

Dividend Analytics HCAT

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History HCAT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation HCAT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.7083
Price Sales TTM 2.2542
Enterprise Value EBITDA -4.7587
Price Book MRQ 1.3552

Financials HCAT

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators HCAT

For 52 weeks

6.6 USD 15.87 USD
50 Day MA 8.5 USD
Shares Short Prior Month 1 299 277
200 Day MA 11.33 USD
Short Ratio 3.18
Shares Short 1 513 025
Short Percent 3.03 %